<div data-mobiledoc= "{"version":"0.3.2","atoms":[],"cards":[],"markups":[["em"],["strong"]],"sections":[[1,"p",[[0,[],0,"In this episode, our Trial By Fire duo interviews "],[0,[0,1],2,"Scott Schliebner"],[0,[],0,". Scott is a clinical drug development executive with over 25 years of experience across the CRO, biotech, and non-profit sectors. They cover the gap between drug development and patient needs and the unique challenges that the industry faces. "]]]]}"> <div>In this episode, our Trial By Fire duo interviews <em><strong>Scott Schliebner</strong></em>. Scott is a clinical drug development executive with over 25 years of experience across the CRO, biotech, and non-profit sectors. They cover the gap between drug development and patient needs and the unique challenges that the industry faces. <a href= "https://guides.clarahealth.com/trial-by-fire-scott/">Transcript - Episode 3</a> <p> </p> </div> </div>

In this episode, our Trial By Fire duo interviews Scott Schliebner. Scott is a clinical drug development executive with over 25 years of experience across the CRO, biotech, and non-profit sectors. They cover the gap between drug development and patient needs and the unique challenges that the industry faces. Transcript - Episode 3

 In this episode, our Trial By Fire duo interviews <em><strong>Scott Schliebner</strong></em>. Scott is a clinical drug development executive with over 25 years of experience across the CRO, biotech, and non-profit sectors. They cover the gap between drug development and patient needs and the unique challenges that the industry faces. <a href="https://guides.clarahealth.com/trial-by-fire-scott/" rel="noopener noreferrer">Transcript - Episode 3</a> <p>&nbsp;</p>  

Industry challenges and gaps between drug development and patients

The Clara Team is excited to introduce our limited podcast series: Trial by Fire, which chronicles candid clinical trial experiences and discusses how we can tackle these issues as an industry and work towards creating a system that takes into account a diverse set of patient perspectives.

Share Industry challenges and gaps between drug development and patients

Sign up to save your podcasts

Industry challenges and gaps between drug development and patients

Industry challenges and gaps between drug development and patients